WATER/AQUA/EAU, GLYCERIN, NIACINAMIDE, CAPRYLIC/CAPRIC TRIGLYCERIDE, GLYCERETH-26, PHENYL TRIMETHICONE, 1,2-HEXANEDIOL, BEHENYL ALCOHOL, POLYMETHYLSILSESQUIOXANE, CHLORELLA VULGARIS EXTRACT, GLUCOSE, CARBOMER, BUTYLENE GLYCOL, CAPRYLYL GLYCOL, FRUCTOOLIGOSACCHARIDES, FRUCTOSE, HIPPOPHAE RHAMNOIDES OIL, TROMETHAMINE, ETHYLHEXYLGLYCERIN, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, CITRUS JUNOS PEEL OIL, TOCOPHERYL ACETATE, DISODIUM EDTA, ECLIPTA PROSTRATA EXTRACT, ECLIPTA PROSTRATA LEAF EXTRACT, CITRUS JUNOS SEED OIL, MORINGA OLEIFERA SEED OIL, HYDROGENATED LECITHIN, CHOLESTEROL, PEG-800, ASCORBIC ACID, TOCOPHEROL, POLYSORBATE 20, CERAMIDE NP, LINOLEIC ACID, RETINOL, CITRUS JUNOS FRUIT OIL, BIOFLAVONOIDS, SH-OLIGOPEPTIDE-1, SH-POLYPEPTIDE-1, SH-OLIGOPEPTIDE-2, SH-POLYPEPTIDE-22, SH-POLYPEPTIDE-45, SH-POLYPEPTIDE-8, SH-POLYPEPTIDE-9
A phase 2 multicenter, open-label, randomized, controlled trial in patients with stage II/III colorectal cancer who are ctDNA positive following resection to compare efficacy of autogene cevumeran versus watchful waiting
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Understanding that framework is essential to understanding what went wrong and why it affects patients who may never have heard the name ProRx before
The new approach in prescribing type 2 diabetes medications is to consider all aspects of the patients health, such as their cardiovascular event risk, kidney health and other comorbidities
